Medical News

DPP4i Score above Sulfonylureas as an Add-on Glucose Lowering Therapy, States DARWIN-T2D Study

DARWIN-T2D, a large retrospective real-world study revealed that addition of dipeptidyl peptidase-4 inhibitor (DPP4i) rather than gliclazide to the...

19 Jun, 2018

 
Email this page
Benefits of Long-Term Excellent Glycemic Control in T1DM Patients-Insights from the DCCT

Type-1 diabetes mellitus (T1DM) patients with an excellent glycemic control over a period of 30 years had substantial reduction in the incidence of...

18 Jun, 2018

 
Email this page
Prevalence of Diabetes and Prediabetes Shooting up Alarmingly, Reports an Indian Survey

One-in every three houses has a diabetes patient, reported a recent Indian study. The DUDS (Delhi urban diabetes survey) conducted in urban Delhi...

14 Jun, 2018

 
Email this page
Tracking the eGFR Trajectories and Studying the Impact of Diabetes on CKD Risk

Diabetes is one of the prime risk factors for kidney function decline, reaffirmed a recent study that tracked the estimated glomerular filtration (...

12 Jun, 2018

 
Email this page

Key Trials

Preservation of Beta-cell Function: Daily Metformin vs. Intermittent Intensive Insulin Therapy

Metformin is superior to intermittent IIT for preservation of beta-cell function and better glycemic control in early Type-2 diabetes patients.

CARDIA Study: Lactation Duration Inversely Associated with Diabetes Progression in Women across the Childbearing Years

The CARDIA study with a 30-year follow-up demonstrated an inverse association between lactation duration and progression of diabetes in women.

Benefits of Initial Combination Therapy of Vildagliptin/Metformin in Asian T2DM Patients

Combination therapy of vildagliptin/metformin demonstrated consistent HbA1c reduction across wide spectrum of drug naïve Asian T2DM patients.

Impact of Canagliflozin on Cardiovascular and Renal Outcomes in Type-2 Diabetes Patients

The CANVAS Program demonstrates that canagliflozin reduces the risk of CV events in type-2 diabetes patients who are at high risk of CVD.

Patient Education

Know More about Diabetes

Diabetes implies high blood sugar levels in blood. Find out more about the cause, risk factors and complications associated with this disease.

Yoga

The ancient science of yoga provides various health benefits to an individual. Know more about the ‘asanas’ that are beneficial for diabetes...

Stretching

Stretching improves our flexibility and physical performance. Understand the correct stretching techniques to reap maximum health benefits from them...

Walking

Walking is a simple exercise with numerous health benefits for all.  A simple, step-wise walking program is important for effective diabetes control...

Our Publications

Mind Matters (Issue 3) - Role of Escitalopram in the Treatment of Comorbid Depression and Diabetes

The presence of depression in patients with diabetes mellitus is of vast importance, as it is usually associated with poor disease control, adverse...

Diabetes Management Series: Cholesterol

Most relevant information on management of dyslipidemia, a common comorbidity observed in diabetes patients, has been summarised in this document.

Drug Therapy for Management of Hyperglycaemia

Brief information on the treatment strategy and selection of oral antihyperglycemic agents in type 2 diabetes is summarised in this document.

Diabetes Management Series: Hypertension

Hypertension elevates the risk of micro-and macro-vascular complications in diabetes. Here is a summary on the BP treatment goals in diabetes...

Slide Library

Clinical Practice Recommendations: ADA 2014

This slide set summarizes the key 2014 clinical practice recommendations of the American Diabetes Association (ADA) on the screening, diagnosis and...

 
Email this page
Diabetic Dyslipidemia

Dyslipidemia is one of the key risk factors for cardiovascular disease (CVD) in diabetes mellitus. This slide set provides information on the...

 
Email this page
Treating Hypertension in Diabetics : Optimal Selection of Antihypertensive Therapy

Hypertension affects 20%-60% of diabetics. It substantially increases the risk of macrovascular and microvascular complications in diabetes. This...

 
Email this page
The ‘Four Facets’ of Glucose Control: Focus on Voglibose and Metformin Combination

This slide set addresses the need to progress from the glucose triad to the glucose pyramid for achieving steady glucose control. The effectiveness...

 
Email this page

Poll

Which is your preferred DPP4 inhibitor for your type 2 diabetes patients with ESRD?
Sitagliptin
18% (2 votes)
Vildagliptin
27% (3 votes)
Linagliptin
45% (5 votes)
No specific choice
9% (1 vote)
Don’t prefer a DPP4 inhibitor
0% (0 votes)
Total votes: 11